Timing of HCG Administration in IUI Cycles

• Status: Unknown status
• Trial end date: 2019-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mohamed Ibrahem Eid; Mohamed Sayed Abdelhafez
• Treatments: Chorionic Gonadotropin

Criteria

Inclusion Criteria:

• Mild male factor infertility or unexplained infertility.

Exclusion Criteria:

• Advanced male factor infertility.

• Polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria.

• Endometriosis.

• Tubal disease.

• Uterine abnormalities or myoma.

• Previous uterine surgery.

• Metabolic or hormonal abnormalities.